September 26, 2022

Volume XII, Number 269

Kala K. Shankle

Attorney Kala Shankle deftly navigates clients through pharmacy laws and drug pricing, reimbursement, and supply chain issues. Her legal counsel is guided by a deep understanding of a client’s business and objectives, coupled with the dynamics of federal and state regulatory landscapes.

For retail and specialty pharmacies, pharmacy benefit managers, insurers, and other health care providers and suppliers, Kala counsels on drug reimbursement by private insurers and government programs, 340B drug program compliance and management, supply chain laws and regulations, and provider licensure and accreditation. She also advises on compliance with fraud and abuse, cannabis, state and federal COVID-19 regulations, and patient/consumer data privacy laws. Separately, she provides guidance to organizations on nonprofit compliance issues.

Before joining Epstein Becker Green, Kala worked as Assistant General Counsel and Director of Health Strategy and Public Policy at a nonprofit national trade association that advocates for chain and regional pharmacies. In those positions, she shaped the association’s policy initiatives and served as the go-to attorney on pharmacy issues, including coverage and reimbursement for prescription drugs or medical services, the COVID-19 response, and innovative pharmacy trends. Previously, Kala was Director of Policy and Regulatory Affairs at a nonprofit national trade association representing independent community pharmacies nationwide, where she advised on a broad range of health care issues, including drug pricing, reimbursement, and prescription supply chain issues.

In her early private practice, Kala served as outside counsel for a state association representing pharmacists. During law school, Kala served as a Committee Staff for the Local and Federal Affairs Committee in the Florida House of Representatives.

Articles in the National Law Review database by Kala K. Shankle